MedMen Enterprises Inc.
MMNFF · OTC
6/25/2022 | 6/26/2021 | 6/30/2020 | 6/30/2019 | |
|---|---|---|---|---|
| Revenue | $141 | $145 | $157 | $130 |
| % Growth | -2.9% | -7.7% | 20.9% | – |
| Cost of Goods Sold | $71 | $78 | $99 | $69 |
| Gross Profit | $70 | $67 | $58 | $61 |
| % Margin | 49.5% | 46.4% | 37% | 46.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $109 | $125 | $200 | $235 |
| SG&A Expenses | $112 | $126 | $211 | $262 |
| Sales & Mktg Exp. | $3 | $1 | $11 | $28 |
| Other Operating Expenses | $19 | $31 | $40 | $21 |
| Operating Expenses | $131 | $157 | $251 | $283 |
| Operating Income | -$61 | -$89 | -$193 | -$222 |
| % Margin | -43.5% | -61.6% | -122.7% | -171% |
| Other Income/Exp. Net | -$114 | -$67 | -$329 | -$22 |
| Pre-Tax Income | -$175 | -$144 | -$515 | -$263 |
| Tax Expense | -$10 | $2 | -$40 | $14 |
| Net Income | -$166 | -$145 | -$476 | -$277 |
| % Margin | -117.6% | -100.3% | -302.8% | -213.2% |
| EPS | -0.14 | -0.27 | -1.76 | -2.62 |
| % Growth | 48.1% | 84.7% | 32.8% | – |
| EPS Diluted | -0.14 | -0.27 | -1.76 | -2.62 |
| Weighted Avg Shares Out | 1,154 | 531 | 270 | 106 |
| Weighted Avg Shares Out Dil | 1,154 | 531 | 270 | 106 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1 | $1 | $1 |
| Interest Expense | $43 | $61 | $49 | $23 |
| Depreciation & Amortization | $26 | $34 | $44 | $24 |
| EBITDA | -$64 | -$55 | -$149 | -$199 |
| % Margin | -45.2% | -37.8% | -94.9% | -152.9% |